What is Kymera Therapeutics's price / book?

Kymera Therapeutics (KYMR) reported price / book of 4.4× in Q1 2026.

How has Kymera Therapeutics's price / book changed year-over-year?

Kymera Therapeutics's price / book increased by 95.4% year-over-year, from 2.3× to 4.4×.

What is the long-term trend for Kymera Therapeutics's price / book?

Over 5 years (2020 to 2025), Kymera Therapeutics's price / book has grown at a -16.6% compound annual growth rate (CAGR), from 9.8× to 3.9×.

What does price / book mean?

Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.

Kymera Therapeutics KYMR Price / book

Price / book at other companies

PfizerPFE

1.8×+0.2×

Johnson & JohnsonJNJ

7.3×+2.1×

Regeneron PharmaceuticalsREGN

2.6×+0.2×

Krystal Biotech, Inc.KRYS

5.9×+0.6×

Protagonist TherapeuticsPTGX

10.3×+6.0×

Spyre Therapeutics, Inc.SYRE

5.9×+3.9×

Other financials

Income statement

See full

Revenue$34.4M+55.5%

Operating income-$84.2M-13.1%

Net income-$69.2M-5.6%

EPS (diluted)-$0.71+13.4%

Balance sheet

See full

Cash & equivalents$144.1M+60.2%

Total debt$82.2M-6.5%

Total equity$1.5B+95.8%

Total assets$1.7B+81.7%

Cash flow

See full

Operating cash flow-$88.8M-12.2%

CapEx$434.0K-7.1%

Free cash flow-$89.3M-12.1%

Valuation

See full

Market cap$7.44B+283%

Enterprise value$7.38B+280%

P/S144.5×+111×

Profitability

See full

Operating margin-697.7%+635pp

Net margin-612%+602pp

FCF margin-474%+92.4pp

Returns & leverage

See full

Return on equity-27.1%-3.7pp

Debt / equity0.1×-0.1×

Current ratio10.8×+2.3×

Where this comes from

Calculated from Kymera Therapeutics’s reported figures.

market cap/total stockholders equity=4.4×

Based on the most recent quarter.

The official record: Kymera Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kymera Therapeutics's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Kymera Therapeutics's price / book?: Kymera Therapeutics (KYMR) reported price / book of 4.4× in Q1 2026.
How has Kymera Therapeutics's price / book changed year-over-year?: Kymera Therapeutics's price / book increased by 95.4% year-over-year, from 2.3× to 4.4×.
What is the long-term trend for Kymera Therapeutics's price / book?: Over 5 years (2020 to 2025), Kymera Therapeutics's price / book has grown at a -16.6% compound annual growth rate (CAGR), from 9.8× to 3.9×.
What does price / book mean?: Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.